"I need to cut through the noise but keep on the pulse of the pharmaceutical market."

The world is changing — and fast. Your target therapy areas and world markets are different, and so are the threats.

Even the ways you conduct your discovery and development activities may be changing. If you can’t keep up with the bombardment of market information, you risk losing that vital piece of intelligence that can affect your success.

Thomson Reuters can equip you with a wealth of pharmaceutical knowledge and business intelligence, enabling you to gain an expert overview of the 'big picture' regarding your own organization and the pharmaceutical industry.

We can help you build a complete profile of your competitors — their pipelines, patents, products, financial performance and market share.

Our data solutions contain chemical and genetic structures, disease state information, dosage, pharmacokinetics, cautions, interactions, clinical applications, adverse effects, comparative efficacy and prescription patterns for thousands of drugs.

With unique insight into the size and growth of the prospective market place and the strategic players, you’ll know who to hire, buy, work or merge with.

Our experts can help you analyze trends in research, study new and emerging methodologies, respond rapidly to threats and changes, and identify and exploit gaps in the market.